苏州贝康医疗股份有限公司（贝康医疗-B，股票代码：02170）于2026年8月3日发布了截至2026年7月31日的股份变动月报表。公告显示，公司注册股本和已发行股份在本报告期内均未发生变动，股本保持稳定。
根据公告，贝康医疗-B当前拥有普通股H股82,713,835股、内资股183,181,817股、未上市外资股7,630,348股，所有股份面值均为每股人民币1元。报告期内，各类别股份数量没有增加或减少，发行总股本仍合计273,526,000元人民币。公司同时确认，自2026年1月1日起并无回购任何上市证券，也无注销或库藏股票活动。
公司在公告中表示，截至本报告期末，上述H股已充分满足香港联合交易所有限公司对公众持股量的要求。公告中亦显示，目前并无股份期权、股权激励计划的相关变动，亦无可换股票据或其他股份发行安排。
本次公告由执行董事梁波签署。公司表示，将继续严格遵守香港联交所《上市规则》及相关法律法规规定。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.